Press release
Cytokine Market Accelerates with Immuno-Oncology Pipeline & U.S.-Japan R&D Alliances | CytoAgents, Cullinan Oncology, Inc, Genentech, Inc, AbbVie Inc
Cytokine Market
Cytokine Market Report by DataM Intelligence offers a detailed assessment of the global immunology and biologics landscape, highlighting market size, key players, and critical growth drivers. With a focus on cytokine-modulating biologics, diagnostics for hyperinflammation, and repurposed small-molecule inhibitors, the report delivers strategic insights for stakeholders from 2025 to 2033.
In 2025, high-impact reviews and translational initiatives from U.S. centers (and dedicated cytokine research consortia) renewed focus on biomarkers and targeted therapies for cytokine storm syndromes, accelerating investment into precision diagnostics and repurposing trials.
Download exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://www.datamintelligence.com/download-sample/cytokine-market?ophp
Cytokine Market Competitors Overview:
CytoAgents, Cullinan Oncology, Inc, Genentech, Inc, AbbVie Inc, Sanofi, Novartis AG, Pfizer Inc, F. Hoffmann-La Roche Ltd , Merck KGaA, GenScript and among others.
Important Industry Updates:
On March 27, 2023, The U.S. Food and Drug Administration (FDA) has approved CLN-617, a fusion protein composed of two potent and synergistic antitumor cytokines, IL-2 and IL-12, with a collagen binding domain intended for retention in the tumour microenvironment (TME) after intratumoral injection, according to Cullinan Oncology, Inc., a biopharmaceutical company focused on modality-agnostic targeted oncology therapies. In a Phase 1 trial, Cullinan Oncology will initially assess CLN-617 in patients with advanced solid tumours.
On June 15, 2023, Genentech, a member of the Roche Group, announced that the FDA had approved Columvi (glofitamab-gxbm) for the treatment of adult patients with relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) that is not otherwise specified or large B-cell lymphoma (LBCL) arising from follicular lymphoma, following two or more lines of systemic therapy.
On May 19, 2023, The FDA has approved EPKINLYTM (epcoritamab-bysp), the first and only T-cell engaging bispecific antibody, for the treatment of adult patients with diffuse large B-cell lymphoma (DLBCL), not otherwise specified (NOS), including DLBCL resulting from indolent lymphoma, and high-grade B-cell lymphoma (HGBL), following two or more lines of systemic therapies.
Methodology and Scope
The Cytokine Market Report is built on a rigorous research methodology that integrates primary interviews, expert insights, and validated secondary data from company reports, industry publications, and reliable databases. Utilizing both bottom-up and top-down approaches, the analysis ensures high data accuracy through triangulation. The report covers current market dynamics, growth opportunities, and key strategic developments across global and regional markets.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/cytokine-market?ophp
Cytokine Market Segments Overview:
∎ By Type
Chemokines
Interferons
Interleukins
Tumor necrosis factor (TNF)
Monokines
Lymphokines
Colony-stimulating factors (CSF)
∎ By Application
Cancer
Orthopedic
Dermatology
Others
∎ By End Users
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Research Institutes
Others
Regional Overview for Cytokine Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking for in-depth insights? Grab the full report: https://www.datamintelligence.com/buy-now-page?report=cytokine-market
The Report Covers:
➡ In-depth analysis of the demand-supply gap, market size estimates, SWOT and PESTEL analysis, along with global market forecasts.
➡ Strategic recommendations with a focused go-to-market approach.
➡ An unbiased evaluation of overall market performance.
➡ Region- and country-specific insights, with customized reports available upon request.
➡ Identification of high-potential and niche segments and regions demonstrating strong growth prospects.
People Also Ask:
➤ What are the current global trends in sales, production, imports, and exports within the Cytokine market?
➤ Who are the leading manufacturers, and what are their production volumes, pricing strategies, and revenue metrics?
➤ What are the major opportunities and challenges facing vendors in this market?
➤ Which product categories, applications, or end-user segments are contributing most to market growth and share?
➤ What are the primary factors driving and restraining growth in the Cytokine market?
Unlock 360° Market Intelligence with 2 Days FREE Trial Access of DataM Subscription Now!: https://www.datamintelligence.com/reports-subscription?ophp
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drugs Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cytokine Market Accelerates with Immuno-Oncology Pipeline & U.S.-Japan R&D Alliances | CytoAgents, Cullinan Oncology, Inc, Genentech, Inc, AbbVie Inc here
News-ID: 4142691 • Views: …
More Releases from DataM intelligence 4 Market Research LLP
United States Railway Fleet Management Market 2025 | Growth Drivers, Key Players …
Market Size and Growth
The global railway fleet management market was valued at $4,816.45 million in 2025 and is estimated to grow to $9,350.85 million in 2031 with a CAGR of 14.19% between 2025 and 2031
Key Developments and Mergers and acquisitions:
Japan:
✅ September 2025: East Japan Railway Company (JR East) and SkyDrive announced an expanded collaboration to integrate rail and electric vertical takeoff and landing (eVTOL) travel. This partnership aims to…
United States Industrial Absorbents Market 2025 | Growth Drivers, Key Players & …
Market Size and Growth
The industrial absorbents market was valued at $4,523.17 million in 2024 and is estimated to grow to $5,645.67 million in 2031 with a CAGR of 4.53% between 2025 and 2031
Recent Mergers and acquisitions:
United States: Recent M&A Activity
✅ In August 2025, American Industrial Partners (AIP) acquired International Paper's Global Cellulose Fibers (GCF) division for $2.5 billion. GCF is a leading producer of absorbent fluff pulp used in…
United States Wood Fuels Market 2025 | Growth Drivers, Key Players & Investment …
Market Size and Growth
The wood fuels market was valued at $15,519.33 million in 2024 and is estimated to grow to $25,305.73 million in 2031 with a CAGR of 10.27% between 2025 and 2031
Key Development:
United States: Recent Industry Developments
✅ In October 2025, Carolina Renewable Products announced a $280 million investment in Orangeburg County, South Carolina. The facility will convert sustainable wood biomass into renewable diesel, biochar, and wood vinegar, creating 155…
United States Dimension Stone Market 2025 | Growth Drivers, Market Forecast, Com …
Market Size and Growth
The global dimension stone market was valued at $5,593.35 million in 2025 and is estimated to grow to $6,950.26 million in 2031.
Key Development:
✅ In July 2025, a major U.S. granite producer resumed operations at its facility, which had been suspended in 2024. This reopening marks a significant recovery in the dimension stone sector.
✅ In March 2025, Holcim announced its strategy, NextGen Growth 2030, aiming for 6% to…
More Releases for Cytokine
Cytokine Release Syndrome Market New Product Development & Latest Trends
Introduction
Cytokine release syndrome (CRS) is a systemic inflammatory response triggered by an excessive activation of the immune system, leading to a surge of pro-inflammatory cytokines. While CRS can occur in severe infections and autoimmune conditions, it has gained heightened significance as a common and potentially life-threatening complication of advanced immunotherapies, particularly chimeric antigen receptor T-cell (CAR-T) therapy, bispecific antibodies, and immune checkpoint inhibitors.
Symptoms range from fever, hypotension, and hypoxia to…
Cytokine Release Syndrome Management Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Cytokine Release Syndrome Management Market - (By Cytokine Type (Tumor Necrosis Factor-TNF, Interleukins-II, Interferons-IFN, Epidermal Growth Factor-EGF), By Therapeutic Application (Cancer, Asthma, Airway Inflammation, Arthritis, Others), By Biomarker Type (Interleukin-10, Interleukin-6, Ferritin, Cluster of Differentiation-163), By Route of Administration (Oral, Intravenous), By End User (Hospitals, Specialty Clinics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast…
Emerging Trends Influencing The Growth Of The Cytokine Release Syndrome Treatmen …
The Cytokine Release Syndrome Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Cytokine Release Syndrome Treatment Market Size Expected to Be by 2034?
The market size for the treatment of cytokine release syndrome has experienced remarkable growth recently. The market value…
Cytokine Release Syndrome Management Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Cytokine Release Syndrome Management Market - (By Cytokine Type (Tumor Necrosis Factor-TNF, Interleukins-II, Interferons-IFN, Epidermal Growth Factor-EGF), By Therapeutic Application (Cancer, Asthma, Airway Inflammation, Arthritis, Others), By Biomarker Type (Interleukin-10, Interleukin-6, Ferritin, Cluster of Differentiation-163), By Route of Administration (Oral, Intravenous), By End User (Hospitals, Specialty Clinics, Others)), Trends, Industry Competition Analysis, Revenue and Forecast…
Key Driver Shaping the Future Cytokine Release Syndrome Treatment Market From 20 …
What Is the Estimated Market Size and Growth Rate for the Cytokine Release Syndrome Treatment Market?
In recent times, the market size for treatments of cytokine release syndrome has seen a rapid increase. The forecast predicts an upsurge from $1.25 billion in 2024 to $1.42 billion in 2025, presenting a compound annual growth rate (CAGR) of 13.7%. A growth surge during the historical period can be credited to factors such as…
Cytokine Market Size, Share, Growth Report and Forecast 2024-2032
According to the report by Expert Market Research (EMR), the global cytokine market is projected to grow at a CAGR of 6% between 2024 and 2032. Aided by the burgeoning applications in medical and research fields, the market is expected to grow significantly by 2032.
Cytokines are a broad category of small proteins that are crucial in cell signalling. Their role is primarily related to immune and inflammatory responses. These proteins…
